20061211
 Celgene Corp.   The Wall Street Journal,  Dec 12, 2006  Celgene Corp. acquired an active-pharmaceutical-ingredient manufacturing facility in Europe from Swiss drug maker Siegfried Ltd. for $46.5 million, with an initial payment of $12.5 million.   
